These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9684101)

  • 21. Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors.
    Saleh M; Wiegmans A; Malone Q; Stylli SS; Kaye AH
    J Natl Cancer Inst; 1999 Mar; 91(5):438-45. PubMed ID: 10070943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetics and immunotherapy: using the genetic landscape of gliomas to inform management strategies.
    Wang JY; Bettegowda C
    J Neurooncol; 2015 Jul; 123(3):373-83. PubMed ID: 25697584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perspectives of immunotherapy in isocitrate dehydrogenase-mutant gliomas.
    Friedrich M; Bunse L; Wick W; Platten M
    Curr Opin Oncol; 2018 Nov; 30(6):368-374. PubMed ID: 30102604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of local immunoresistance in glioma.
    Albesiano E; Han JE; Lim M
    Neurosurg Clin N Am; 2010 Jan; 21(1):17-29. PubMed ID: 19944963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolytic adenoviruses.
    Vecil GG; Lang FF
    J Neurooncol; 2003 Dec; 65(3):237-46. PubMed ID: 14682374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses.
    Maxwell R; Luksik AS; Garzon-Muvdi T; Lim M
    Curr Neurol Neurosci Rep; 2017 Jun; 17(6):50. PubMed ID: 28488122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
    Juratli TA; Schackert G; Krex D
    Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotherapy for glioma: Current management and future application.
    Xu S; Tang L; Li X; Fan F; Liu Z
    Cancer Lett; 2020 Apr; 476():1-12. PubMed ID: 32044356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-mediated immunotherapy: a new approach to the treatment of malignant glioma.
    Yang L; Ng KY; Lillehei KO
    Cancer Control; 2003; 10(2):138-47. PubMed ID: 12712008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Oncolytic viral therapy of gliomas: review of the literature].
    Arrese I; González P; Miranda P; Pérez-Núñez A; Pascual B; Lobato RD
    Neurocirugia (Astur); 2005 Apr; 16(2):158-68. PubMed ID: 15915305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular immunity and immunotherapy of brain tumors.
    Prins RM; Liau LM
    Front Biosci; 2004 Sep; 9():3124-36. PubMed ID: 15353342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neurosurgery and molecular biology: (series 12) immunological therapy for gliomas].
    Kijima H; Shimizu K
    No Shinkei Geka; 1999 Dec; 27(12):1071-7. PubMed ID: 10629887
    [No Abstract]   [Full Text] [Related]  

  • 33. Adenovirus-mediated p53 gene therapy for human gliomas.
    Lang FF; Yung WK; Sawaya R; Tofilon PJ
    Neurosurgery; 1999 Nov; 45(5):1093-104. PubMed ID: 10549925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New therapeutic approaches to treatment of malignant gliomas: chemotherapy and immunotherapy.
    Mahaley MS; Gillespie GY
    Clin Neurosurg; 1983; 31():456-69. PubMed ID: 6680086
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy.
    Kamran N; Kadiyala P; Saxena M; Candolfi M; Li Y; Moreno-Ayala MA; Raja N; Shah D; Lowenstein PR; Castro MG
    Mol Ther; 2017 Jan; 25(1):232-248. PubMed ID: 28129117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted Local Therapy for Management of Intracranial High-Grade Gliomas.
    Paldor I; Chaichana KL; Brem H; Tyler BM
    Prog Neurol Surg; 2018; 32():159-171. PubMed ID: 29990982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine gene therapy for malignant glioma.
    Okada H; Pollack IF
    Expert Opin Biol Ther; 2004 Oct; 4(10):1609-20. PubMed ID: 15461572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunotherapy in brain tumors].
    De Carli E; Delion M; Rousseau A
    Ann Pathol; 2017 Feb; 37(1):117-126. PubMed ID: 28111040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy as an adjuvant treatment for malignant gliomas: from bench to bedside.
    Germano IM; Binello E
    J Neurooncol; 2009 May; 93(1):79-87. PubMed ID: 19430884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigen-receptor gene-modified T cells for treatment of glioma.
    Ikeda H; Shiku H
    Adv Exp Med Biol; 2012; 746():202-15. PubMed ID: 22639170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.